![VENTAVIS 10 UG/ML SOLUTION POUR INHALATION PAR NEBULISEUR B/30 AMP DE 2ML | PharmNet - Encyclopédie des médicaments en Algérie | Propriété Sarl ESAHTI VENTAVIS 10 UG/ML SOLUTION POUR INHALATION PAR NEBULISEUR B/30 AMP DE 2ML | PharmNet - Encyclopédie des médicaments en Algérie | Propriété Sarl ESAHTI](https://pharmnet-dz.com/ImageHandler.ashx?imageurl=/img/medics/4687.png)
VENTAVIS 10 UG/ML SOLUTION POUR INHALATION PAR NEBULISEUR B/30 AMP DE 2ML | PharmNet - Encyclopédie des médicaments en Algérie | Propriété Sarl ESAHTI
![These highlights do not include all the information needed to use VENTAVIS safely and effectively. See full prescribing information for VENTAVIS. VENTAVIS® (iloprost) inhalation solution, for oral inhalation use Initial U.S. Approval: These highlights do not include all the information needed to use VENTAVIS safely and effectively. See full prescribing information for VENTAVIS. VENTAVIS® (iloprost) inhalation solution, for oral inhalation use Initial U.S. Approval:](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=ventavis-15.jpg&id=649464)
These highlights do not include all the information needed to use VENTAVIS safely and effectively. See full prescribing information for VENTAVIS. VENTAVIS® (iloprost) inhalation solution, for oral inhalation use Initial U.S. Approval:
![Safety and efficacy of RT234 vardenafil inhalation powder on exercise parameters in pulmonary arterial hypertension: phase II, dose-escalation study design | Respiratory Research | Full Text Safety and efficacy of RT234 vardenafil inhalation powder on exercise parameters in pulmonary arterial hypertension: phase II, dose-escalation study design | Respiratory Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12931-022-02262-9/MediaObjects/12931_2022_2262_Fig1_HTML.jpg)